Alpha Tau Medical Ltd. (NASDAQ:DRTSW) Short Interest Update

Alpha Tau Medical Ltd. (NASDAQ:DRTSW) was the target of a large decline in short interest in the month of March. As of March 13th, there was short interest totaling 3,511 shares, a decline of 19.0% from the February 26th total of 4,337 shares. Based on an average trading volume of 21,842 shares, the days-to-cover ratio is currently 0.2 days.

Alpha Tau Medical Stock Down 10.9%

NASDAQ:DRTSW traded down $0.11 during trading hours on Monday, reaching $0.89. 688 shares of the company’s stock were exchanged, compared to its average volume of 48,300. Alpha Tau Medical has a 1-year low of $0.13 and a 1-year high of $1.50. The company has a 50-day moving average of $1.03 and a 200 day moving average of $0.60.

About Alpha Tau Medical

Alpha Tau Medical Ltd. is a clinical-stage medical technology company focused on the development of alpha-emitting radiation therapy for the treatment of solid tumor cancers. The company’s proprietary Alpha DaRT (Diffusing Alpha-emitters Radiation Therapy) platform leverages the short-range, high-energy alpha particles emitted by radium-224 to penetrate tumor tissues more effectively than conventional external-beam radiation. By implanting thin, needle-like sources directly into a tumor, Alpha DaRT delivers concentrated doses of radiation to malignant cells while sparing surrounding healthy tissue.

The Alpha DaRT technology is designed to enhance local tumor control in a variety of solid tumors, including head and neck, breast, skin, and pancreatic cancers.